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Summary: Purpose: Mesial temporal sclerosis (MTS) is the 
most common and important pathology in temporal lobe epi- 
lepsy (TLE), and its presence in magnetic resonance imaging 
(MRI) scans is strongly correlated with a successful surgical 
outcome. Despite the general assumption that patients with 
MTS respond poorly to medication, the long-term prognosis for 
such patients has not yet been investigated. We studied the 
overall clinical prognosis of patients with MTS and analyzed 
the factors related to the degree of medical responsiveness. 
Methods: Case patients were actively followed up at the 
Yonsei Epilepsy Clinic in Seoul, Korea, for >2 years. A struc- 
tured interview and a thorough clinical evaluation were con- 
ducted. MRI scans, at the field strength of 1.0 or 1.5 Tesla, 
were performed with T,- and T,-weighted coronal and axial 
spin-echo images. All coronal slices were S5-mm thick with 
no gap. Two neurologists and one radiologist determined the 
presence of MTS in MRIs by visual analysis. 
Results: The MTS group consisted of 104 patients. Of these, 
26 (25%) were completely controlled with adequate therapy, 
and 40 (38%) were intractable, despite aggressive anticonvul- 
sant polytherapy. The remaining 37% had their seizure frequen- 
cies reduced by >SO%, but were not seizure free. The age of 
seizure onset was significantly younger in the intractable group 
than in the well-controlled group. Patients with a history of 
febrile convulsions or with epileptiform discharges in their 
electroencephalogram (EEG) had poorer seizure control (p < 
0.05) than those who did not. Among the 16 patients who had 
no previous treatment, five (31%) became seizure free, and two 
were intractable. 
Conclusions: Not all patients with MTS are medically in- 
tractable; 25% of the patients in our study achieved complete 
control while receiving medication. Poor seizure control was 
related to an early age of seizure onset, a history of febrile 
convulsions, and epileptiform discharges on the EEG. Key 
Words: Mesial temporal sclerosis-MRI-Seizure- 
Epilepsy-Prognosis. 
Hippocampal sclerosis is the most common pathologic 
finding in in temporal lobe epilepsy (TLE). It is found in 
50-70% of cases, after temporal lobectomy for intrac- 
table temporal lobe epilepsy (1). 
Magnetic resonance imaging (MRI) is the most valu- 
able imaging technique for epilepsy. It can more accu- 
rately evaluate mass and other structural lesions of the 
MTS without surgical exposure. In this study, we as- 
sessed the prognosis for seizure control of patients whose 
MTS was found through MRI and determined factors 
influencing the course of their disease and responsive- 
ness to medical treatment. 
METHODS 
temporal lobe than computed tomography (CT) (2-4). 
The MRI abnormalities of hippocampal sclerosis-an in- 
creased hippocampal signal on T,-weighted images, a 
decreased signal on T, -weighted images, and hippocam- 
pal atrophy-have been extensively described, and the 
presence of these features on MRI have enabled physi- 
cians to diagnose hippocampal sclerosis in 80-90% of 
cases ( 5 ) .  These features also indicate mesial temporal 
sclerosis (MTS). Therefore it is possible to recognize 
We evaluated MRI scans from 104 patients at the 
Yonsei Epilepsy Program in Seoul, Korea, from January 
1989 to September 1996. The patients were referred 
there for expert consultation or came on their own. We 
first selected a patient group from those with clinical 
features of complex partial seizures or who had a tem- 
poral focus on interictal electroencepalograms (EEGs). 
We excluded patients who had an aura-visual, simple 
motor, or simple sensory-that had a non-temporal lobe 
origin. Patients who had had loss of consciousness or 
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nausea and vomiting after a head injury were considered 
to have experienced head trauma' 
Two kinds of MRI machines were used. One was a 
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1.5-Telsa magnet (Signa, General Electric, Milwaukee, 
WI, U.S.A.) and the other was a 1.0-Telsa magnet (Mag- 
netom Impact, Siemens, Danvers, MA, U.S.A.). T,- 
weighted images were spin-echo sequences, with echo 
times (TE) of 80 and 85 ms and repetition time (TR) of 
2,200 and 4,500 ms. Ti-weighted images were TE 15-ms 
and TR 600-ms sequences. We used only T i  and T, 
signal images without inversion recovery since an inver- 
sion recovery method has been part of our MRI protocol 
since 1997. 
We performed axial views parallel to the long axis of 
the hippocampus. In coronal views, we transected the 
long axis of the hippocampus to evaluate its oval-shaped 
appearance. All slices were 5-  or 3-mm thick with a 
no-gap method. 
Three observers (two epileptologists and one neurora- 
diologist) evaluated the MRIs independently, without 
prior access to information about the patients or each 
other’s opinions. Each observer was asked to make an 
overall diagnosis and to confirm the lateralization of the 
lesion. They classified the scans as normal or as MTS. 
The case patients for this study were chosen if at least 
two observers diagnosed MTS. We excluded patients 
with dual abnormal findings, such as temporal lobe at- 
rophy, vascular malformations, cerebral infarction, tu- 
mor, and cortical dysplasia of the temporal lobe. We also 
excluded those suspected of having bilateral hippocam- 
pal sclerosis and those with a loss of internal morpho- 
logic structure because of visual uncertainty. 
The EEG was performed for about 40 minutes by the 
routine method with nasopharyngeal electrodes. An ab- 
normal EEG was defined as epileptiform discharges 
around the temporal lobe. 
The patients were followed up for more than 2 years. 
The average seizure frequency during the second year 
was used for evaluating seizure frequency, because the 
frequency in the first year was subject to change due to 
adjustments in medication. The initial seizure frequency 
was determined by historical reviews; during the follow- 
up period, we obtained seizure frequencies from the sei- 
zure diaries of the patients. 
We divided the patients into three groups according to 
their outcome after 2 years of follow-up. The first group 
consisted of patients who were seizure free during the 
second year of follow-up. The second group consisted of 
patients with improved seizure control whose seizure fre- 
quency had decreased >50% from their initial rate. The 
third group consisted of patients with poor seizure con- 
trol whose seizure frequency had decreased <50% or had 
not changed from their initial frequency. 
We also asked the patients about their antiepileptic 
drug (AED) history to determine if they had been treated 
adequately before visiting our epilepsy clinic. If the se- 
rum AED levels were in the therapeutic range at their 
first visit, they were considered to have been adequately 
treated. 
RESULTS 
The average age of patients at onset of seizures was 
14.6 f 7.3 years (range, 3-3.5 years), and the average 
duration of illness was 13.1 r 7.9 years. There were 60 
men (57%) and 44 women patients (43%). Fifty-three 
patients (51%) had MTS in the left side and 51 (49%) 
had it in the right. No significant correlation was found 
between the location of the lesion, either in the right 
or left side, and seizure outcome, nor was there a differ- 
ence in seizure outcome between the men and women 
(Table 1). 
Thirty-seven patients (35%) had experienced febrile 
convulsions; 20 (1 9%) had experienced meningoenceph- 
alitis; and 10 (10%) had experienced head trauma. 
According to the criteria of the follow-up outcome, 26 
(25%) patients belonged to the seizure-free group, 38 
(37%) to the improved-seizure-control group, and 40 
(38%) to the poor-seizure-control group. 
The onset age was 16.9 & 8.5 years for the seizure-free 
group, 15.9 & 6.9 years for the improved-seizure-control 
group, and 13.0 & 5.9 years for the poor-seizure-control 
group (p < 0.05). The duration of illness in each group 
was not significantly different: 12.8 f 6.9 years, 13.7 & 
8.9 years, and 12.4 f 8.2 years, respectively. 
The median seizure frequency per month during the 
follow-up period of the improved-seizure-control group 
was three (IQ range, 1-7), compared with five for the 
poor-seizure-control group (range, 1-1 8). 
Based on the routine EEGs that were taken during 
each patient’s first visit, 14 (40%) with normal EEGs 
became seizure free, whereas only 12 (18%) of those 
with focal epileptiform discharges did (p < 0.05, x2 = 
5.33). 
Thirty percent of the MTS patients in our study had 
experienced febrile convulsions. Patients with a history 
of a febrile convulsion (49%) had worse seizure control 
than patients who had no definite history (28%, p < 0.01, 
x2 = 8.34). Other events such as central nervous system 
(CNS) infection, head trauma, and hypoxia were not cor- 
related with prognosis for seizure control. 
Of the patients previously treated before referral to our 
center, those who had been treated adequately were less 
likely to achieve improved seizure control than those 
who had been inadequately treated (p < 0.05, x2 = 8.47). 
After the 2-year follow-up period, no patients receiving 
three or more AEDs were seizure free, whereas 21 pa- 
tients with monotherapy (43%) were. 
Sixteen patients had not taken any AEDs before vis- 
iting our clinic. A11 were started with AED treatment. Of 
those, five (3 1 %) were seizure free after 1 year of treat- 
ment with monotherapy, nine (56%) were improved, and 
two (13%) were poorly improved with medications. 
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TABLE 1. Clinicul dutu of patients 
Characteristics 
Seizure free Improved control Poor control 
(n = 26) (n = 38) (n = 40) 
(%) (%I 
Age of onset (yr)” 
Duration of illness (yr) 
Lesion side 
Left 
Right 
Male 
Female 
Normal 
Abnormal 
Risk factors in history 
None 
Febrile convulsions“ 
CNS infection 
Head trauma 
Others (hypoxia, etc.) 
Treatment history 
Not treated 
Inadequately treated 
Adequately treated 
Antiepileptic drug usage 
Monotherapy 
Polytherapy with 2 drugs 
Polytherapy with 3 or more drugs 
Sex 
EEG‘ 
16.9? 8.5 
1 2 3  2 6.9 
13 (25) 
13 (25) 
14 (23) 
12 (27) 
14 (40) 
12 (18) 
1 1  (38) 
3 (8) 
6 (30) 
3 (38) 
3 (30) 
5 (31) 
7 (15) 
21 (43) 
0 (0) 
14 (34) 
5 (14) 
15.9 2 6.9 
13.7 * 8.9 
23 (43) 
15 (29) 
21 (35)  
17 (39) 
1 1  (31) 
27 (40) 
10 (34) 
16 (43) 
6 (30) 
3 (30) 
3 (38) 
9 (56)  
16 (39) 
13 (28) 
24 (49) 
13 (36) 
1 ( 5 )  
13.0 2 5.9 
12.4 k 8.2 
17 (32) 
23 (46) 
25 (42) 
15 (34) 
10 (29) 
29 (42) 
8 (28 )  
18 (49) 
8 (40) 
4 (401 
2 (24) 
2 (13) 
11  (27) 
26 (57) 
4 (8) 
18 (50) 
18 (95) 
‘* Significance between seizure-free group and poor-seizure-control g o u p  (p < 0.05). 
DISCUSSION 
Temporal lobe epilepsy is the most common cause of 
complex partial seizures. Any kind of lesion in the tem- 
poral lobe can result in TLE. By the site of a lesion, we 
usually classify a disorder as mesial TLE or lateral TLE. 
Lateral TLE is caused by various lesions, but mesial TLE 
has a relatively homogeneous, pathologic substrate, 
which can often be treated surgically. The term “mesial 
temporal lobe epilepsy” is considered a unique entity of 
TLE. The term “mesial temporal sclerosis” was intro- 
duced by Falconer and Taylor (6). 
The pathologic term “hippocampal sclerosis (HS)” is 
common in the autopsies of patients with epilepsy and 
includes neuronal loss and secondary glial fibrosis (1,7). 
Until recently, no diagnostic imaging tool, not even CT, 
could evaluate MTS. Advances made in MRI techniques 
have made the identification of small mesial temporal 
structures possible. Cell loss, if sufficient, will appear in 
the MRI scan as changes in signal intensity and volume 
loss (8,9). The basic features of MRI change in MTS that 
we found were a decreased signal and atrophic change in 
T,-weighted images and an increased signal in T, images 
(10, I 1). Other helpful features were asymmetry of the 
temporal horns and enlarged sylvian fissures in the ven- 
tral orientation. In T,-weighted images, we attempted to 
visualize the cerebrospinal fluid around the temporal 
horn and the choroidal fissures (1 1). To evaluate MTS, 
MRI scans interpreted by visual inspection alone had a 
lower determination value than volumetric estimations of 
the hippocampus (1  2), but when hippocampal volume 
ratios were ~ 0 . 7 ,  visual detection was as accurate as that 
of volumetrics (13). 
An early age of onset is one of the poor prognostic 
factors of TLE. Lindsay, et al. (14) found that patients 
whose onset of seizures was before 2 years of age had a 
bad prognosis. (In children under age 15 years with tem- 
poral epilepsy, the age at onset was considered the age of 
the first seizure, whatever its nature.) Fois, et al. (15) 
found that the unresponsive group in their study had an 
earlier mean age of onset than the responsive group. The 
results of this study also showed that an early onset age 
affected the outcome more than the duration of the ill- 
ness, and that a significant inversion correlation existed 
between the age of onset and the grade of HS (16). 
Focal epileptiform discharges in anterior and midtem- 
poral regions predicted intractability to medication (1 5). 
Patients with normal EEG features had a better prognosis 
than those with abnormal ones. 
A previous study found that the side of focus in an 
EEG predicted the prognosis, with the left side showing 
poorer results (14). We considered the MTS side as the 
lesion side, but could not find any significant difference 
between the right and the left. 
A relatively high percentage of the patients with MTS 
who were candidates for surgical treatment or for TLE 
had a history of febrile convulsions (17-20). There is 
much speculation regarding the relation between febrile 
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convulsions and MTS. One theory is that MTS is caused 
by a factor independent of the epilepsy, another that 
MTS is caused as a consequence of epilepsy. Murakami 
et al. (21) found that I I (58%) of their 19 patients had 
febrile convulsions, and that among them, 7 (37%) had 
prolonged ones. Reports have shown that prolonged fe- 
brile convulsions play an etiologic role in the develop- 
ment of MTS, that they correlate positively with hippo- 
campal atrophy, and are related to the duration of illness 
(22). Our results also showed that the patients with a 
history of febrile convulsions have a poorer prognosis 
than those without. No significant correlation between 
the prognosis and the duration of illness was noted. 
The dosage of AEDs may be another important con- 
sideration for patients. New patients visiting our clinic 
are usually referral cases. Of the case patients, 85 were 
referred because their epilepsy had not improved, even 
with medication. Judging from the serum drug level at 
their first visit, 41 patients had been given an insufficient 
dosage. Almost 30 patients showed improvement or were 
seizure free after dosage adjustment or drug change. 
When dosages were adjusted, many intractable patients 
improved; however, no patients receiving three or more 
drugs were seizure free after a 2-year follow-up period. 
Because the seizure-free rate after temporal lobectomy of 
MTS is -70%, patients whose seizures are not well con- 
trolled with two drugs should be considered for surgery 
rather than prescribed additional drugs (23). 
Many surgical reports have shown that a large propor- 
tion of temporal lobectomy patients had pathologic ab- 
normalities, especially HC. In a study of newly diag- 
nosed seizure patients, those with hippocampal sclerosis 
had a worse prognosis than those with other MRI find- 
ings (24), and Murakami et al. (21) found that only two 
out of their 19 MTS patients were controlled with medi- 
cation. We may assume from these results that seizures 
of patients with HS are intractable and need surgical 
treatment. But we found that 25% of our patients became 
seizure free while receiving medication. Those with no 
previous treatment were few, but five such patients be- 
came seizure free, and 56% improved with better medi- 
cal treatment. These results suggest that MTS patients 
are not always resistant to medical treatment, and 2-year 
trials of AED therapy may be appropriate. But patients 
whose seizures are only poorly controlled with three or 
more drugs should be considered for possible surgery 
without further delay. 
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